Shanghai Jeyou Pharmaceutical Co., Ltd.
Shanghai Jeyou Pharmaceutical Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study of Sosimerasib in Combination With IN10018 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation | non-small cell lung carcinoma | Not yet recruiting | Phase 3 | 2026-09-24 | NCT07833202 | |
| A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion | Neoplasms by Site, Pleural Effusion, Pleural Effusion, Malignant, Thoracic Neoplasms, myeloproliferative disorder, chronic, with eosinophilia, neoplasm, pleural disorder, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 2 | 2026-06-16 | NCT07649369 | |
| Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy | CIPN - Chemotherapy-Induced Peripheral Neuropathy | Not yet recruiting | Phase 1 | 2026-05-22 | NCT07601386 |